Deep brain stimulation outcomes and management of childhood‐onset dystonia and associated hyperkinetic movements disorders
AIM: To examine longitudinal changes in self-selected goals and dystonia severity over 1 year, 2 years, and 5 years after deep brain stimulation (DBS) in children and young people (CYP) with dystonia and other hyperkinetic movement disorders, using CYP and caregiver reports. METHOD: The retrospective cohort study included follow-up to 5 years after DBS, with the number of participants varying across time points. In the CYP group, 62 participants were included at the 1-year follow-up, 50 at 2 years, and 17 at 5 years. In the parental and caregiver sample, 146 participants were included at 1 year, 125 at 2 years, and 51 at 5 years. Changes across time were assessed using Wilcoxon signed-rank tests, the Canadian Occupational Performance Measure (COPM), and Burke-Fahn-Marsden Dystonia Rating Scale - motor severity (BFMDRS-m). Analyses were stratified by key characteristics of participants, including sex, age at surgery, Manual Ability Classification System (MACS) level, Gross Motor Function Classification System (GMFCS) level, and aetiology. RESULTS: Median COPM performance increased from 2.8 to 6.1 (baseline to 5 years), while COPM satisfaction improved from 2.6 to 7.6; parent/caregiver reports showed similar trends. BFMDRS-m scores decreased from 81.0 to 70.0, with the largest improvements in the first year. COPM changes were greater in monogenic dystonia and participants classified in MACS levels I to III. BFMDRS-m improvements were more pronounced in monogenic dystonia, participants classified in GMFCS levels I to III, and those aged at least 12 years. INTERPRETATION: DBS showed sustained improvements in motor function and self-selected goals, with consistent findings across CYP and caregiver reports. Functional gains were observed despite limited dystonia reduction, particularly in dystonic cerebral palsy.
Authors
- Daniel Edward Lumsden (ORCID: https://orcid.org/0000-0002-5524-6177)
- Richard Ρ Selway
- Verity M. McClelland (ORCID: https://orcid.org/0000-0001-5180-4242)
- Harutomo Hasegawa (ORCID: https://orcid.org/0000-0002-3711-6790)
- Laura Ainaga
- Jean‐Pierre Lin (ORCID: https://orcid.org/0000-0001-9314-2259)
- Eva María Navarrete‐Muñoz (ORCID: https://orcid.org/0000-0002-1494-5676)
- Hortensia Gimeno (ORCID: https://orcid.org/0000-0003-1488-6415)
- Sinead Barkey
- Keyoumars Ashkan
Institutions
- Universitat de Miguel Hernández d'Elx (ES)
- University of Alicante (ES)
- Queen Mary University of London (GB)
- King's College London (GB)
- Guy's and St Thomas' NHS Foundation Trust (GB)
- King's College Hospital NHS Foundation Trust (GB)
- Hospital General Universitario de Alicante Doctor Balmis (ES)
Publication Details
- Journal
- Developmental Medicine & Child Neurology
- Published
- 2026-08-27
- DOI
- https://doi.org/10.1111/dmcn.70481
- Primary Topic
- Neurological disorders and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institute for Health and Care Research
- Department of Health and Social Care
- Rosetrees Trust
- Medical Research Council